Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus placebo after PCI for acute myocardial infarction with symptomatic left ventricular failure
2004-002732-25Phase 4Completed
- Sponsor
- Ullevål University Hospital
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levosimendan in Acute Heart Failure (AHF) and myocardial infarction (MI) (2 arms), sponsored by Ullevål University Hospital. Primary endpoints: Change in regional myocardial contractility, Change in brain natriuretic peptide and 4 more. Started Sep 2005; status: completed.
02
Drugs
levosimendan
03
Conditions
Acute Heart Failure (AHF)myocardial infarction (MI)
Beyond the preview
Go deeper on 2004-002732-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002732-25.